{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T18:12:36Z","timestamp":1755799956241,"version":"3.44.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100017691","name":"Guangxi Key Research and Development Program","doi-asserted-by":"publisher","award":["GK AB24010172"],"award-info":[{"award-number":["GK AB24010172"]}],"id":[{"id":"10.13039\/501100017691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","award":["2024GXNSFAA010315","2018GXNSFAA281141"],"award-info":[{"award-number":["2024GXNSFAA010315","2018GXNSFAA281141"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.rbmo.2025.104872","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T12:08:14Z","timestamp":1739966894000},"page":"104872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatic fat infiltration and clinical indicators in polycystic ovary syndrome: insights from MRI HISTO sequences"],"prefix":"10.1016","volume":"51","author":[{"given":"Min","family":"Ling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangnian","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingfen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zisan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rbmo.2025.104872_bib0001","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2019-000352","article-title":"Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome","volume":"7","author":"Asfari","year":"2020","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.rbmo.2025.104872_bib0002","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"10.1016\/j.rbmo.2025.104872_bib0003","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3390\/biomedicines10092193","article-title":"Clinical Usefulness of Non-Invasive Metabolic-Associated Fatty Liver Disease Risk Assessment Methods in Patients with Full-Blown Polycystic Ovary Syndrome in Relation to the MRI Examination with the Ideal IQ Sequence","volume":"10","author":"Blukacz","year":"2022","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.rbmo.2025.104872_bib0004","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.29797","article-title":"Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials","volume":"68","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.rbmo.2025.104872_bib0005","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1016\/j.ultrasmedbio.2019.06.415","article-title":"Abdominal Wall Thickness Affects Liver Stiffness Measurements by 2-D Shear Wave Elastography in Patients with Chronic Liver Disease","volume":"45","author":"Cho","year":"2019","journal-title":"Ultrasound Med Biol"},{"issue":"6","key":"10.1016\/j.rbmo.2025.104872_bib0006","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","volume":"59","year":"2016","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.rbmo.2025.104872_bib0007","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000443344","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"9","year":"2016","journal-title":"Obes Facts"},{"issue":"5","key":"10.1016\/j.rbmo.2025.104872_bib0008","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.rbmo.2025.104872_bib0009","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.rbmo.2025.104872_bib0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.rbmo.2025.104872_bib0011","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/apt.12963","article-title":"Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease","volume":"40","author":"Fedchuk","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.rbmo.2025.104872_bib0012","doi-asserted-by":"crossref","DOI":"10.1080\/09513590.2024.2359031","article-title":"Nonalcoholic fatty liver disease risk in polycystic ovary syndrome patients","volume":"40","author":"Fern\u00e1ndez-Alonso","year":"2024","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"10.1016\/j.rbmo.2025.104872_bib0013","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jhep.2018.09.024","article-title":"Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib","volume":"70","author":"Jayakumar","year":"2019","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.rbmo.2025.104872_bib0014","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jmri.26575","article-title":"Accuracy and precision of proton density fat fraction measurement across field strengths and scan intervals: A phantom and human study","volume":"50","author":"Kim","year":"2019","journal-title":"J Magn Reson Imaging"},{"issue":"11","key":"10.1016\/j.rbmo.2025.104872_bib0015","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.21037\/qims-22-393","article-title":"The spectrum of magnetic resonance imaging proton density fat fraction (MRI-PDFF), magnetic resonance spectroscopy (MRS), and two different histopathologic methods (artificial intelligence vs. pathologist) in quantifying hepatic steatosis","volume":"12","author":"Kim","year":"2022","journal-title":"Quant Imaging Med Surg"},{"issue":"4","key":"10.1016\/j.rbmo.2025.104872_bib0016","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10334-020-00825-9","article-title":"Low-level fat fraction quantification at 3 T: comparative study of different tools for water-fat reconstruction and MR spectroscopy","volume":"33","author":"Ko\u0159\u00ednek","year":"2020","journal-title":"Magma"},{"issue":"7","key":"10.1016\/j.rbmo.2025.104872_bib0017","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.rbmo.2025.104872_bib0018","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3348\/kjr.2018.0174","article-title":"Fat Quantification in the Vertebral Body: Comparison of Modified Dixon Technique with Single-Voxel Magnetic Resonance Spectroscopy","volume":"20","author":"Lee","year":"2019","journal-title":"Korean J Radiol"},{"issue":"4","key":"10.1016\/j.rbmo.2025.104872_bib0019","doi-asserted-by":"crossref","first-page":"416","DOI":"10.14218\/JCTH.2023.00421","article-title":"Effects of the Pituitary-targeted Gland Axes on Hepatic Lipid Homeostasis in Endocrine-associated Fatty Liver Disease \u2013 A Concept Worth Revisiting","volume":"12","author":"Li","year":"2024","journal-title":"J Clin Transl Hepatol"},{"issue":"5","key":"10.1016\/j.rbmo.2025.104872_bib0020","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.acra.2021.06.006","article-title":"Six-point DIXON and Magnetic Resonance Spectroscopy Techniques in Quantifying Bone Marrow Fat in Sickle Cell Disease","volume":"29","author":"Lins","year":"2022","journal-title":"Acad Radiol"},{"issue":"1","key":"10.1016\/j.rbmo.2025.104872_bib0021","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12916-023-02775-0","article-title":"The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome","volume":"21","author":"Liu","year":"2023","journal-title":"BMC Med"},{"issue":"3","key":"10.1016\/j.rbmo.2025.104872_bib0022","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1530\/EJE-16-1063","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease","volume":"177","author":"Macut","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.rbmo.2025.104872_bib0023","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/humrep\/dew076","article-title":"Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome","volume":"31","author":"Macut","year":"2016","journal-title":"Hum Reprod"},{"issue":"11","key":"10.1016\/j.rbmo.2025.104872_bib0024","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.crad.2020.07.031","article-title":"Differences in multi-echo chemical shift encoded MRI proton density fat fraction estimation based on multifrequency fat peaks selection in non-alcoholic fatty liver disease patients","volume":"75","author":"Mart\u00ed-Aguado","year":"2020","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1016\/j.rbmo.2025.104872_bib0025","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.rbmo.2020.04.024","article-title":"Tissue fat quantification by magnetic resonance imaging: proton density fat fraction in polycystic ovary syndrome","volume":"41","author":"Oguz","year":"2020","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"10.1016\/j.rbmo.2025.104872_bib0026","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2036.2012.05121.x","article-title":"Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD","volume":"36","author":"Permutt","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.rbmo.2025.104872_bib0027","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.23235","article-title":"Are women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysis","volume":"14","author":"Ramezani-Binabaj","year":"2014","journal-title":"Hepat Mon"},{"issue":"5","key":"10.1016\/j.rbmo.2025.104872_bib0028","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/jmri.23741","article-title":"Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration","volume":"36","author":"Reeder","year":"2012","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"10.1016\/j.rbmo.2025.104872_bib0029","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"issue":"12","key":"10.1016\/j.rbmo.2025.104872_bib0030","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s40618-017-0708-9","article-title":"Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis","volume":"40","author":"Rocha","year":"2017","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"10.1016\/j.rbmo.2025.104872_bib0031","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/lt.24965","article-title":"Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?","volume":"24","author":"Satkunasingham","year":"2018","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.rbmo.2025.104872_bib0032","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/jgh3.12512","article-title":"Non-alcoholic fatty liver disease in premenopausal women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"5","author":"Shengir","year":"2021","journal-title":"JGH Open"},{"issue":"4","key":"10.1016\/j.rbmo.2025.104872_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.rbmo.2025.104872_bib0034","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","article-title":"Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population","volume":"288","author":"Szczepaniak","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.rbmo.2025.104872_bib0035","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1148\/radiol.14140754","article-title":"Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease","volume":"274","author":"Tang","year":"2015","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.rbmo.2025.104872_bib0036","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12020-015-0640-8","article-title":"Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?","volume":"51","author":"Targher","year":"2016","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.rbmo.2025.104872_bib0037","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.rbmo.2025.104872_bib0038","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/metabo12040298","article-title":"Nonalcoholic Fatty Liver Disease and Endocrine Axes-A Scoping Review","volume":"12","author":"Von-Hafe","year":"2022","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.rbmo.2025.104872_bib0039","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12978-018-0519-2","article-title":"A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis","volume":"15","author":"Wu","year":"2018","journal-title":"Reprod Health"},{"issue":"2","key":"10.1016\/j.rbmo.2025.104872_bib0040","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1148\/radiol.2017170550","article-title":"Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis","volume":"286","author":"Yokoo","year":"2018","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.rbmo.2025.104872_bib0041","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/mrm.25054","article-title":"Liver fat quantification using a multi-step adaptive fitting approach with multi-echo GRE imaging","volume":"72","author":"Zhong","year":"2014","journal-title":"Magn Reson Med"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648325000793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648325000793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T06:18:47Z","timestamp":1755670727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648325000793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1472648325000793"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2025.104872","relation":{},"ISSN":["1472-6483"],"issn-type":[{"type":"print","value":"1472-6483"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic fat infiltration and clinical indicators in polycystic ovary syndrome: insights from MRI HISTO sequences","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2025.104872","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104872"}}